Clinical Trial Update: Study of GnRH-A [Leuprorelin(Lorelin Depot] Plus Leterozole +/- Everolimus for Premenopausal Women With Metastatic Breast Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating GnRH agonist leuprorelin plus letrozole, with or without everolimus, in premenopausal women with metastatic breast cancer has completed…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Everolimus (everolimus)
• Letrozole (letrozole)
• Leuprorelin (Lorelin Depot) (leuprorelin)

Snippet

Sponsor: Asan Medical Center | Conditions: Metastatic Breast Cancer | Phase 2 | Status: COMPLETED